Milestones: 2009 - Present
December 2010
Vanguard becomes the only provider of temporary modular/mobile healthcare services to be registered with the Care Quality Commission – the independent regulator of health and social care services in England. In accordance with regulation changes, Vanguard’s full range of services is covered by the CQC registration, having previously been registered as a nurse agency.
November 2010
Vanguard receives a huge boost to its flourishing operations in The Netherlands and Europe by securing the OK OKé certificate from European technology giant Cofely. The award recognises the high standard of its mobile theatre, and further reinforces Vanguard’s focus on The Netherlands as a key potential market.
October 2010
Vanguard Healthcare is welcomed into the NHS Partners Network (NHSPN) – the leading trade association for service providers working within the National Health Service. Having provided mobile healthcare solutions to many NHS organisations throughout its ten year history, Vanguard is now able to adopt a more prominent role in the addressing of key healthcare issues through its membership in the Network.
February 2010
Vanguard Healthcare appoints noted industry expert Dr Maurizio Pupi as International Business Director. Dr Pupi, who joined from a senior role at European healthcare giants Alliance Medical, is charged with spearheading Vanguard’s international operations with an immediate focus on offering the company’s unique mobile services to healthcare providers on the Continent.
November 2009
Vanguard Healthcare exhibits for the first time at Medica – the world’s largest international healthcare conference in Dusseldorf, Germany – with a £1 million laminar flow operating theatre forming a key attraction of the exhibition. The show is hailed an ‘incredible success’ by the Vanguard team, with almost 2,000 delegates visiting the unit.
1 April 2009
Vanguard Healthcare is acquired from Nuffield Health in a management buyout. The original founders of the business re-join the management in order to strengthen and support the team and enable the company to explore additional areas of commercial activity, including international markets. Vanguard’s core market will remain their partnership with the NHS.
